Quinapril and Hydrochlorothiazide 20/25 (Quinapril and Hydrochlorothiazide 20/25) — NDC 69097-831 by Cipla USA Inc.
Quinapril and Hydrochlorothiazide 20/25 (Quinapril and Hydrochlorothiazide 20/25) — NDC 69097-831 by Cipla USA Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: Quinapril and Hydrochlorothiazide 20/25; Generic name: Quinapril and Hydrochlorothiazide 20/25; Product NDC: 69097-831.
| Brand name | Quinapril and Hydrochlorothiazide 20/25 |
|---|---|
| Generic name | Quinapril and Hydrochlorothiazide 20/25 |
| Product NDC | 69097-831 |
| Labeler | Cipla USA Inc. |
| Dosage form | TABLET |
| Route | ORAL |
| Active ingredients | HYDROCHLOROTHIAZIDE 25 mg/1; QUINAPRIL HYDROCHLORIDE 20 mg/1 |
| Pharmacologic class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] |
| Marketing category | ANDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →